For users of glargine insulin compared to users of non-glargine insulin, a decreased risk of colon cancer, as well as a marginally significant increased risk of breast cancer and prostate cancer, was observed ( 9 , 51 ).
← all excerpts
The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
1
—
—